Literature DB >> 26211835

HIV-1 Exploits the Host Factor RuvB-like 2 to Balance Viral Protein Expression.

Xin Mu1, Yajing Fu2, Yiping Zhu3, Xinlu Wang1, Yifang Xuan1, Hong Shang2, Stephen P Goff3, Guangxia Gao4.   

Abstract

The correct ratio of the HIV-1 structural protein Gag to the envelope protein (Env) is important for maximal virion infectivity. How the virus ensures the production of Gag and Env proteins in an appropriate ratio remains unknown. We report that HIV-1 exploits the host factor RuvB-like 2 (RVB2) to balance relative expression of Gag and Env for efficient production of infectious virions. RVB2 inhibits Gag expression by interacting with both the encoded Matrix (MA) domain of Gag protein and 5' UTR of the translating mRNA and promoting mRNA degradation in a translation-dependent manner. This inhibitory activity of RVB2 is antagonized by Env through competitive interaction with MA, allowing Gag synthesis to proceed when Env levels are adequate for virion assembly. In HIV-1-positive patients, RVB2 levels positively correlate with viral loads and disease progression status. These findings reveal a mechanism by which HIV-1 regulates its protein expression.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26211835     DOI: 10.1016/j.chom.2015.06.018

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  16 in total

Review 1.  Viral Evasion and Manipulation of Host RNA Quality Control Pathways.

Authors:  J Robert Hogg
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

Review 2.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

3.  In Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells.

Authors:  Johannes Nemeth; Valentina Vongrad; Karin J Metzner; Victoria P Strouvelle; Rainer Weber; Patrick Pedrioli; Ruedi Aebersold; Huldrych F Günthard; Ben C Collins
Journal:  Mol Cell Proteomics       Date:  2017-02-21       Impact factor: 5.911

4.  SUN1 Regulates HIV-1 Nuclear Import in a Manner Dependent on the Interaction between the Viral Capsid and Cellular Cyclophilin A.

Authors:  Xinlong Luo; Wei Yang; Guangxia Gao
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

5.  HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localization.

Authors:  Charles Bou-Nader; Frauke Muecksch; Janae B Brown; Jackson M Gordon; Ashley York; Chen Peng; Rodolfo Ghirlando; Michael F Summers; Paul D Bieniasz; Jinwei Zhang
Journal:  Cell Host Microbe       Date:  2021-08-11       Impact factor: 31.316

Review 6.  Interactions between the HIV-1 Unspliced mRNA and Host mRNA Decay Machineries.

Authors:  Daniela Toro-Ascuy; Bárbara Rojas-Araya; Fernando Valiente-Echeverría; Ricardo Soto-Rifo
Journal:  Viruses       Date:  2016-11-23       Impact factor: 5.048

7.  Elucidating the in vivo interactome of HIV-1 RNA by hybridization capture and mass spectrometry.

Authors:  Rachel A Knoener; Jordan T Becker; Mark Scalf; Nathan M Sherer; Lloyd M Smith
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

Review 8.  Principles and Properties of Stress Granules.

Authors:  David S W Protter; Roy Parker
Journal:  Trends Cell Biol       Date:  2016-06-09       Impact factor: 20.808

9.  RuvB-Like Protein 2 Interacts with the NS1 Protein of Influenza A Virus and Affects Apoptosis That Is Counterbalanced by Type I Interferons.

Authors:  Yimeng Wang; Jianhong Zhou; Samuel G Mackintosh; Yuchun Du
Journal:  Viruses       Date:  2021-05-31       Impact factor: 5.048

10.  M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner.

Authors:  Qin Wang; Xiaolin Zhang; Yuling Han; Xinlu Wang; Guangxia Gao
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.